UK Department of Health Guidance on Prescribing for Impotence Following the Introduction of Sildenafil: Potential to Contain Costs in the Average Health Authority District

Author： Ashton-Key M.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.12, 2002-01, pp. : 839-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sildenafil prescribing guidance reduces UK specialist costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 384, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The Cost to the United Kingdom National Health Service of Managing Erectile Dysfunction: The Impact of Sildenafil and Prescribing Restrictions

By Wilson E.C.F.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 879-889

Adis International

Access to resources Recommend Favorite

Rise in Psychotropic Drug Prescribing in Children in the UK: An Urgent Public Health Issue

By Wong I.C.K.   Camilleri-Novak D.  

Drug Safety, Vol. 26, Iss. 15, 2003-01 ,pp. : 1117-1118

Adis International

Access to resources Recommend Favorite

Following an alert from the Singapore Health Sciences Authority, Health Canada has advised consumers not to use Urat Madu

By  

Reactions Weekly, Vol. 1, Iss. 1151, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The future of health research in the UK

By Smye Stephen W   Wynick David  

Clinical Medicine, Vol. 7, Iss. 6, 2007-12 ,pp. : 542-543

Royal College Of Physicians

Access to resources Recommend Favorite